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ABSTRACT 
The “gut microbiota” is widely accepted as an integral part of the gut homeostasis, and is 
thought to contribute to the establishment of intestinal barrier. Growing body of research 
suggest that the influence of gut microbiota on host development and physiology reaches 
beyond the gastrointestinal tract, and the brain is not an exception. The brain plays a critical 
role in regulating systemic homeostasis through continuous monitoring of body energy state 
and integration of the peripheral signals. Evidences of microbiota impact on brain at different 
levels including development, neurobiology, and even behavior have been documented. This 
thesis places two aspects of central regulation of homeostasis under the spotlight, and 
explores the potential impact of gut microbes in this context: (i) Brain regulation of local 
homeostasis through the function of the blood-brain barrier (BBB). The BBB is a specialized 
barrier that segregates the neural tissue from the circulation and controls the provision of 
nutrients to the brain. An intact BBB is critical for maintaining a homeostatic environment for 
normal function of the brain cells. (ii) Brain  regulation of systemic homeostasis in relevance 
to anorexia nervosa. Anorexia nervosa is a serious eating disorder with altered homeostatic 
function. Dysbiosis in the gut microbiota have been reported in anorectic patients. 
By taking advantage of germ-free mouse model, we showed that in the absence of gut 
microbiota, the integrity and function of the BBB is impaired during the intrauterine period, 
suggesting that maternal gut microbiota mediates the development and maturation of the 
BBB. Impaired BBB integrity persisted into adulthood and was associated with decreased 
expression of endothelial tight junction proteins including occludin, claudin-5 and zona 
occludens-1. The alterations in structure and permeability of the BBB were restored by 
introducing normal gut flora into the germ-free mice, reinforcing the role of gut microbiome 
for the integrity of the BBB. Furthermore, we showed that short-chain fatty acids (SCFAs, 
bacterial metabolites of dietary fiber fermentation) improve BBB integrity in line with 
previous observations that SCFAs enhance the integrity of intestinal epithelial barrier. Germ-
free mice monocolonized with Clostridium tyrobutyricum that mainly produces butyrate or 
with Bacteroides thetaiotaomicron which produces acetate and propionate exhibited 
decreased BBB permeability. Treatment with butyrate salt mimicked the effects. The 
influence of SCFAs might be mediated by epigenetic mechanisms as monocolonized and 
SCFA-treated germ-free mice displayed enhanced levels of histone acetylation in brain 
lysates. 
Preterm birth is associated with impaired development and vascular fragility in the brain. 
During the critical early postnatal period, normal brain growth and maturation may be 
negatively affected by the prematurity-related factors such as nutrient deprivation or a serious 
infection. We used a preterm porcine model to study the effects of gestational age, early 
feeding, and infection on brain barriers following preterm birth. Preterm pigs spontaneously 
develop diet- and microbiota-related diseases including necrotizing enterocolitis. We showed 
that preterm piglets have impaired BBB-associated protein expression, decreased endothelial 
integrity, and enhanced blood-CSF barrier permeability in comparison to term counterparts. 
The observed impairment in endothelial integrity measured as astroglial perivascular 
coverage persisted into postnatal day five independent of enteral or parenteral feeding. Next, 
to investigate brain barrier function in preterm piglets under inflammation, we fed a group of 
animals with formula which is known to increase the risk of necrotizing enterocolitis. Our 
results indicate that severe necrotizing enterocolitis following five day formula treatment is 
associated with increased systemic inflammation, impaired blood-CSF barrier, enhanced 
neuronal death and elevated IL-6 levels in the hippocampus. 
As an example of systemic homeostasis, we hypothesized that gut microbiota has a functional 
relevance in anorexia nervosa, a disease with altered homeostatic function. We transplanted 
fecal microbiota from a female individual with anorexia nervosa and a sex-matched healthy 
control into female germ-free mice. Following fecal microbiota transplantation, some of the 
phenotypic aspects of anorexia were replicated in the recipient mice, including reduced 
weight gain, elevated serum corticosterone levels, and increased anxiety-like behavior 
measured by open-field test. This hypothesis was further reinforced by the fact that mice 
subjected to these transplantations display significant changes in gene-expression in the 
nucleus accumbens (but not in the hippocampus), a region implicated in reward and affected 
in patients with anorexia.  
In summary, the findings in this thesis reinforce the proposed impact of gut microbiota on 
host homeostasis. Specifically, on local level, we showed the influences on BBB 
development and function, and on systemic level, we demonstrated the effects on genes 
involved in energy homeostasis in nucleus accumbens.  Future studies will uncover the exact 
mechanisms underlying the impact of gut microbiota on the brain. 
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1 INTRODUCTION 
 
1.1 THE GUT MICROBIOTA 
Human body, similar to other multicellular organisms, is a mosaic of eukaryotic cells, 
prokaryotic cells, and viruses. Symbiosis of these different life forms provides an enriched 
gene pool that potentially enhances the ability of the organism as a whole (holobiont) for 
survival. The resident microorganisms in/on the body including bacteria, fungi, yeast, 
bacteriophages, and archea are collectively known as the “microbiota”. So far, the microbiota 
research has been mainly focused on the bacterial component, thus the other life forms have 
been less investigated1–4.  It is estimated that the number of bacterial cells in the body is 
roughly the same as the number of human cells5. Globally, various projects such as Human 
Microbiome Project, MetaHIT, and Asian Gut aim to identify and characterize the human 
microbiome. These projects commonly focus on specific body sites including the gut, nasal 
passages, oral cavity, skin, and urogenital tract. A recent study performed on the circulating 
cell-free DNA rather than looking at specific individual sites, showed that only 1% of the 
non-human cells in the body mapped to the existing database6. The results from this study 
suggest that the microbiota is vastly more diverse than previously known, and a large fraction 
of the microbiota is still uncharacterized.  Nevertheless, the gastrointestinal tract represents 
the most heavily colonized organ, populated by more than 500 bacterial species7. The early 
colonizers of the gut are facultative anaerobes, and the neonatal gut microbiota can be 
characterized by low diversity and dominance by Proteobacteria and Actinobacteria phyla 8,9. 
During the first years of life, the gut microbiota shifts towards a more complex and diverse 
adult-like community with enhanced population of strict anaerobes. By the age of 3-5 years, 
the gut microbiota forms a stable community that fully resembles adult microbiota 
predominated by Firmicutes and Bacteroidetes phyla9,10. Different environmental factors 
affect the development of the infant microbiota during the perinatal period including mode of 
delivery, gestational age, genetics, diet, and antibiotic treatment11–13 (Fig. 1). 
1.1.1 Early development and effects of perinatal factors: mode of delivery, 
gestational age and breast milk 
It is thought that colonization of the body by microorganisms initiates rapidly following 
birth14. However, isolation of microbes from semen, placenta, amniotic fluid, meconium (first 
stool of mammalian infants), and umbilical cord blood has challenged the previously 
accepted already in-utero11,15–17. Nevertheless, the early life events during and shortly after 
birth can be influential in priming the gut microbiota11. 
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Figure 1. Graphical illustration of perinatal factors that shape infant gut microbiota.  
 
 
One of these critical factors is the mode of delivery. Infants born through vaginal delivery are 
predominantly seeded with microbes from vaginal and fecal flora of the mother such as 
Lactobacillus and Bifidobacterium spp.18. In contrast, babies delivered by C-section are 
colonized by microbes that resemble the microbial members of the skin flora including 
Staphylococcus, Corynebacterium, and Propionibacterium spp18. Compared to vaginally-
delivered infants, the gut microbiota diversity is reduced in babies born by C-section. 
Microbiota aberrancies following C-section are associated with delayed maturation of the 
immune system and increased disease risk later in life19,20.  
Other sources of vertical microbial transmission from mother to the offspring are colostrum 
and breast milk. In addition to providing the infant with fundamental nutritional elements and 
bioactive molecules, colostrum and breast milk harbor distinct microbial communities21,22. It 
is estimated that 1 x 104 to 1 x 106 bacteria are passed on to the infant through consumption 
of ~800 mL of milk per day23. Furthermore, some components of human milk have prebiotic 
activities. Prebiotics are non-digestible food ingredients that promote the growth of beneficial 
Mode of Delivery
Vaginal Cesarian
Gestational Age
TermPreterm
Preterm Early Term Full Term
Week 35 36 37 38 39 40 41
Feeding Practice
Formula Breast-feeding
GeneticAntibiotics
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microorganisms in the intestines. The milk components with prebiotic activities facilitate the 
establishment of specific groups of bacteria over the others. For instance, oligosaccharides 
which are found abundantly in human breast milk stimulate the growth of bifidobacteria and 
staphylococci24,25. Healthy breast-fed infants are reported to have two times more 
Bifidobacterium cells in their fecal microbiota compared to formula-fed infants26. In fact, 
compared to formula feeding, exclusive breast feeding is associated with a distinct microbiota 
which promotes the immune system, particularly by developing populations of memory T 
cells and T helper 17 cells27–29. 
Gestational age is another factor that can affect the establishment of gut microbiota in 
newborn infants. Preterm birth, occurring earlier than 37 completed weeks of gestation, is 
thought to perturb the optimal development of the gut microbiota. The microbiota in preterm 
infants is characterized by decreased diversity and reduced number of  Bifidobacterium and 
Bacteroides compared to full-term infants30. Notably, preterm birth is often confounded with 
C-section and antibiotic treatment which can also interfere with normal development of gut 
microbiota18,31. In a study analyzing the gut microbiota in infants following parenteral 
antibiotic treatment, the number of Bifidobacterium and Lactobacillus was shown to be 
reduced and was not fully recovered in eight weeks31. Furthermore, composition of the 
microbiota in colostrum and breast milk was suggested to be affected by the mode of delivery 
and gestational age. This could partly contribute to the alteration of gut microbiota in 
preterm-delivered infants22,32. Investigating the impact of gut microbiota perturbation in 
preterm infants could enhance our understanding of various pathologies associated with 
preterm birth. One of the most severe short term complications of preterm birth is necrotizing 
enterocolitis (NEC). It is thought that increased expression of bacterial receptor Toll-like 
receptor 4 (TLR-4) in the premature gut and enhanced reactivity of intestinal mucosa to 
microbial ligands, in part contribute to the onset of the disease33.  Moreover, independent 
reports indicate that Proteobacteria is the predominant phyla in preterm infants with NEC 
whereas it does not account for more than 40% of total bacteria in no NEC controls34,35. 
Whether the altered gut microbiota reported in NEC is the cause or consequence of the 
disease remains to be further investigated.  
1.1.2 Microbiota in gut-brain axis 
Comorbidities between bowl diseases and alterations of emotional states have long been 
appreciated, and a role for “gut microbiota-brain axis” in the pathology of such diseases has 
been postulated36. An example is the irritable bowel syndrome (IBS) which often co-occurs 
with psychiatric conditions including anxiety and depression. Dysbiosis of the gut microbiota 
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has been reported in the IBS patients37. Increased Firmicutes: Bacteroides ratio found in some 
IBS patients has been correlated with anxiety and depression38. Other studies have suggested 
that treatment with Bifidobacterium probiotic strains or a prebiotic which stimulates the 
growth Bifidobacterium can alleviate the diseases symptoms39–41. Probiotics are live 
microorganisms which provide health benefits when consumed. Another example of co-
occurring gastrointestinal and neurological diseases is autism spectrum disorder (ASD). 
Gastrointestinal disturbances and intestinal barrier dysfunction are frequently reported in 
ASD patients. In two experimental murine models showing ASD features (maternal immune 
activation model and in-utero exposure to valproic acid), alterations in postnatal development 
of gut microbiota have been associated with intestinal and behavioral deficits related to the 
disease42,43.  
The communication between the gut microbiota and the brain seems to be bidirectional as 
various forms of stress in the host can affect the composition and function of the gut 
microbiota. Mice exposed to a social stressor, were shown to have altered bacterial 
population in the intestines (decreased Bacteroides, increased Clostridium), and enhanced 
circulating levels of interleukin 6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1). 
Antibiotic treatment revoked stressor-induced increase in circulating cytokines in these mice, 
suggesting that microbiota mediates cytokine production in response to a stressor44. In a 
mouse model of maternal separation, early-life stress was shown to induce dysbiosis in the 
gut microbiota that persists into adulthood. Altered microbiota profile was associated with 
anxiety-like behavior. Interestingly, maternal separation in germ-free mice did not induce 
such behavior.45   
On developmental level, the gut microbiota modulates various processes including 
myelination, neurogenesis, and microglia maturation46. Multiple independent studies have 
revealed that mice devoid of gut microbiota have increased myelination in prefrontal cortex47, 
altered dendritic morphology48, less responsive and immature microglia49–51, and decreased 
hippocampal neurogenesis52. Several putative mechanisms have been proposed to mediate the 
integration of the signaling between the gut microbiome and the nervous system: 
Neuronal signaling- The vagus nerve is a bundle of parasympathetic nerve fibers that 
conveys information between the periphery (including the gastrointestinal tract) and the 
brain. Anxiety-like behavior induced by dextran sulfate sodium-induced colitis in mice was 
shown to be dependent on the vagus nerve. Introduction of B. longum which is known to have 
anxiolytic effects, could not alleviate the symptoms in vagotomized mice53. Notably, 
treatment with L. rhamnosus and B. infantis was protective against colitis in both 
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vagotomized and control mice suggesting that gut microbiota-brain interaction via the vagus 
nerve might be specific to certain bacterial strains and other signaling mechanisms might be 
involved54.  
Endocrine and neuroendocrine communications- The enteroendocrine cells of the gut 
produce various hormones and peptides including gastrin, cholecystokinin, glucagon-like 
peptide 1, peptide YY (PYY), that are implicated in appetite regulation through 
communication with the brain. The lumen-projecting microvilli of enteroendocrine cells and 
their proximity to the gut microbiota raise the possibility of the cross-talk between the 
microbes and these cells. In fact, in an elegant study, Breton et al. suggested that bacterial 
peptides can affect host appetite through modulating the brain function. The authors showed 
that after food intake, E.coli (in its stationary phase) produces a protein that stimulate the 
releases of PYY by enterendocrine cells which further activates the anorexigenic neurons in 
the hypothalamus55.  
Bacterial metabolites- In addition to microbiota-derived neuroactive molecules, other 
bacterial products can potentially mediate the communication between the gut microbiota and 
the brain. Short-chain fatty acids (SCFAs) including acetate, propionate, and butyrate are 
bacterial fermentation products which are suggested to influence brain and behavior in the 
host56,57. Feeding rats with a diet rich in fermentable carbohydrates was shown to induce 
anxiety-like behavior and impair the memory58. In human, elevated levels of fecal propionic 
acid was associated with anxiety behavior in IBS patients59. Furthermore, increased substrate 
availability for bacterial fermentation due to carbohydrate malabsorption has been correlated 
to depression60. SCFAs also seem to modulate microglia maturation and function. Provision 
of SCFAs in the drinking water was shown to restore the defective microglia observed in 
germ-free mice. Interestingly, mice deficient in SCFA receptor FFAR-2 displayed microglia 
defects similar to those found under germ-free condition61. Another metabolic effect 
attributed to the gut microbiota is the modulation of circulating tryptophan availability. 
Tryptophan is an amino acid precursor for 5-HT, kynurenine, and indole-containing 
metabolites. Although germ-free and antibiotic-treated mice display elevated tryptophan 
levels in the plasma compared to conventional animals62,63, kynurenine metabolism64, 
circulating 5-HT and indole levels62 were decreased indicating that gut microbiota contributes 
to the conversion of tryptophan into its metabolites. Introduction of gut microbiota to germ-
free mice post weaning was shown to be sufficient to restore the altered levels of peripheral 
tryptophan and kynurenine pathway metabolism and to normalize the reduced anxiety 
behavior62. 
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Immune system. Elevated concentrations of inflammatory cytokines such as interleukin 6 
and C-reactive protein (CRPss) have been reported in psychiatric disorders including 
depression65. Manipulation of gut microbiota composition by probiotics was shown to 
influence the systemic cytokine levels both in experimental animal models and in human66–68, 
suggesting that alterations of gut microbiota might influence the behavior through changes in 
cytokine levels. In rat maternal separation model of depression, treatment with probiotic 
Bifidobacterium infantis attenuated exaggerated IL-6 response and improved depression-like 
behavior66, pointing to the potential therapeutic values of probiotics for psychiatric diseases.  
1.2 BRAIN AND REGULATION OF HOMEOSTASIS  
The brain has a key role in maintaining the body in balance in response to environmental 
fluctuations through homeostatic regulation of body temperature, food intake, energy 
expenditure, glucose metabolism, sleep, and composition of blood ions and minerals.69 
Monitoring the state of the body and integration of the peripheral signals, requires 
coordinated interaction between the brain and the periphery. Furthermore, CNS regulation of 
systemic homeostasis is dependent on a local homeostatic microenvironment which enables 
the brain cells to function optimally.  
This thesis is devoted to two aspects of CNS regulation of homeostasis: 1) Regulation of the 
local homeostasis of the brain through the function of the blood-brain barrier, 2) Regulation 
of systemic homeostasis with a focus on anorexia nervosa, a disorder with altered 
homeostatic function. A potential role for the gut microbiota in these two contexts has been 
hypothesized and investigated.   
1.3 BLOOD-BRAIN BARRIER AS A KEY COMPONENT FOR CNS 
HOMEOSTASIS 
The molecular trafficking across the brain is tightly and selectively controlled through the 
function of a specialized barrier known as the blood-brain barrier (BBB). The BBB is formed 
by the tight junctions at the endothelium lining the microvessels of the brain. An intact BBB 
protects the brain from potential neurotoxic and harmful compounds while the passage of 
nutrients and energy substrates is facilitated by transporters at brain endothelium70. Unlike 
what the term “barrier” suggests, the properties and function of the BBB are dynamic and can 
be modulated in different pathological or non-pathological conditions and/or in response to 
CNS or circulatory factors71,72. Alteration of tight junction proteins and increased BBB 
permeability have been reported in conditions such as peripheral inflammation73, aging74,75, 
and chronic sleep deprivation76. Interestingly, in the latter instance, BBB integrity was shown 
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to be restored following sleep recovery76. An example of BBB alteration in response to 
circulating factors is the enhanced receptor-mediated transcytosis of urocortin to the brain 
following leptin injection77. Moreover, it has been suggested that the BBB can also be 
modulated transiently perhaps to facilitate the passage of circulating growth factors and 
antibodies or sampling the plasma composition or to protect the brain under conditions such 
as oxidative stress or hypoxia by tightening the junctional proteins78. 
1.3.1 Molecular and cellular structure of the blood-brain barrier 
The tight junction proteins of the BBB are present at the apical side (facing the lumen) of the 
endothelial cell membrane and include occludin, claudins, and junctional adhesion molecules 
(JAMs). These proteins are linked to the cytoskeleton through cytoplasmic scaffolding 
proteins called zona occludentes (ZOs). ZOs enhance the effectiveness of the tight 
junctions72. ZO-1 is a member of the ZO family which has been implicated in the 
angiogenesis, and barrier formation79. Other transmembrane proteins present at the basal side 
of the endothelial membrane provide structural integrity for the cells by holding them 
together. These proteins, including vascular endothelial cadherin (VE-cadherin) and platelet 
endothelial cell adhesion molecule (PECAM), are known as adherens junction proteins70 
(Fig. 2). While the BBB tight junctions limit the paracellular passage of large hydrophilic 
molecules, smaller lipid-soluble molecules can diffuse across the lipid membrane. Metabolic 
products such as glucose and amino acids are actively transported, and some proteins such as 
insulin are taken up by receptor-mediated transcytosis70.  
The normal function of the BBB also depends on orchestrated activities of other cellular 
components of the neurovascular unit including astrocytes, pericytes, and nerve endings in 
addition to the endothelial cells (Fig. 2). Co-culturing the endothelial cells with astrocytes or 
astrocyte-conditioned media have been shown to enhance barrier function by decreasing the 
permebility80. More recently, pericytes and neurons were also shown to induce similar effects 
in vitro72,81.  
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Figure 2. BBB molecular structure and cellular associations. Graphical illustrations (A,B) and 
transmission electron microscope images from mouse brain depicting (A,C) cross-sections of 
neurovascular unit, and (B,D) components of endothelial tight junctions. Tight junctions are marked 
by squares in (C).  
JAM: Junctional Adhesion Molecule, PECAM: Platelet Endothelial Cell Adhesion Molecule, VE-
cadherin: Vascular Endothelial cadherin.  
 
Astrocytes display close physical and biochemical interactions with endothelial cells at their 
end-foot processes78. Several mechanism have been suggested for the regulatory impact of 
astrocyte on BBB integrity, including angiotensinogen-mediated posttranslational 
modification of occludin, enhancing tight junctions through secretion of sonic hedgehog, 
suppression of tight junction disruptive pathway, and induction of occludin phosphorylation 
through production of apolipoprotein E molecules APOE-2 and APOE-3 (cholesterol and 
phospholipid transporters)82.  
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Pericytes are contractile cells that ensheath the endothelial cells of the microvessels 
throughout the body and in the brain. Capillary bed of the CNS is known to have the highest 
perycite coverage83. Pericytes are embedded in the basement membrane where they interact 
with the endothelial cells by means of direct contact or paracrine signaling. Mice deficient in 
platelet-derived growth factor receptor-β (PDGFR-β), a marker of the pericytes, exhibit 
increased BBB permeability and do not survive. Hypomorphic mutation of PDGFR-β gene 
results in viable mice with reduced PDGFR-β signaling and fewer pericytes than their 
littermates. The enhanced vascular permeability in these mice is associated with alterations in 
transcytosis rather than defective tight junction proteins. Pericytes are also suggested to be 
involved in the spatial guidance and polarization of the astrocyte end-feet84.  
1.3.2 Blood-brain barrier development 
The development of the BBB begins during embryogenesis as soon as the blood vessels 
penetrate the brain tissue. The newly formed blood vessels express tight junction proteins and 
some nutrient transporters82,85. However, the structural and functional maturation of the BBB 
only occurs when the endothelial cells come into contact with pericytes and astroglia84,86. 
This leads to substantial decreases in the permeability of the BBB and the rate of transcytosis, 
which in mice occurs at E15-E16.587,88. The involvement of astrocytes in BBB integrity 
begins during the first and second postnatal weeks (as marked by AQP-4 staining) in rodents, 
indicating that they are more involved in the maintenance of the BBB especially during the 
early postnatal life rather than in its induction84.In contrast, pericytes were shown to be 
necessary for the formation of the BBB during embryogenesis84. In human, the astrocyte are 
already present at the last stage of gestation, suggesting that they might contribute to the 
functional and structural properties of the BBB in a more complex manner than in rodents84.   
1.3.3 Gut microbiota and barrier integrity 
During the past few years, there has been a growing interest to understand the role of gut 
microbiota in regulating the intestinal barrier based on the observed alterations in gut 
microbiota composition and diversity (dysbiosis) in the intestinal disorders including 
inflammatory bowel disease and irritable bowel syndrome89–92. The barrier function in the gut 
is very complex and comprised of various layers including microbial, chemical (mucin), 
physical, and immunological barriers. The physical barrier is formed by a single layer of 
epithelial cells lining the lumen sealed by transmembrane tight junction proteins. The 
adherens junctions and desmosomes link the adjacent epithelial cells mechanically93. In vitro 
studies indicate that treating cultured intestinal epithelial cells with bacteria or bacterial 
products, enhance the trans-epithelial resistance of the cells and alter protein expression of the 
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tight junctions94,95. Human intestinal epithelial cell lines H-29 and Caco-2 exposed to live 
(but not heat-inactivated) probiotics S. thermophilus and L. acidophilus exhibited increased 
trans-epithelial resistance, decreased permeability and enhanced activation of ZO-1 and 
occludin95. Colonization of the germ-free mice with a common gut resident B. 
thetaiotaomicron is associated with nearly 300 fold increase in epithelial expression of small 
proline-rich protein-w2 which plays an important role in fortifying the intestinal epithelial 
barrier function96. Interestingly, bacterial products, namely SCFAs, were shown to improve 
tight junction integrity and barrier function in vitro97 as well as in experimental animals98. 
Inoculation with Bifidobacterium longum that produces high levels of acetate enhances 
intestinal barrier integrity in mice devoid of bacteria57. So far, few mechanisms have been 
identified through which the SCFAs exert their effects, including inhibition of histone 
deacetylases (HDACs) and/or signaling via G protein-coupled receptors GPR41, GPR43, and 
GPR109A57. 
Dysbiosis-associated disruption of tight and adherens junction proteins has been implicated in 
other diseases such as obesity, and type 1 diabetes99,100. Prebiotic treatment of obese mice 
(ob/ob) in favor of  Bifidobacterium spp is shown to be beneficial for tight junction integrity 
and intestinal barrier permeability101. In another study, the gut barrier dysfunction in a mouse 
model of maternal immune activation was improved following treatment with a commensal 
bacterium Bacteroides fragilis. This experimental model displays features of autism spectrum 
disorder accompanied by impairment in gut barrier function, a comorbidity that is observed in 
a subset of autistic individuals. The enhanced barrier function in mice treated with bacteria 
was associated with increased protein expression of tight junctions in the colon. Interestingly, 
autism-related behavior was also ameliorated after the treatment42.  
In addition to the microbiota effects locally on the intestinal barrier, there are some evidence 
suggesting that it can influence a remote barrier in the body namely blood-testis barrier 
(BTB). Similar to the intestinal epithelial barrier, the BTB is formed between the specialized 
epithelial cells of the testis by tight and adeherns junction proteins. Despite of different spatial 
organization, the junctional proteins of the BTB have similar molecular structure and function 
to those of intestinal epithelial barrier102. Mice devoid of gut microbiota are shown to have 
defective BTB permeability and cell junction proteins, suggesting that the microbiota 
modulate BTB integrity. Monocolonization of germ-free mice with Clostridium 
Tyrobutyricum, a butyrate producing bacterium, restores BTB integrity and cell junction 
protein levels103.  
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1.4 NEUROBIOLOGY OF ENERGY HOMEOSTASIS AND FEEDING 
The homeostatic perspective of body energy regulation was first proposed by Claude Bernard 
and Walter Cannon, suggesting that there is a balance between food intake and energy 
expenditure. They attributed the balanced internal milieu to the ability of the body to monitor 
the energy state and make adjustments to sustain the stability104. Regulation of feeding, as a 
complementary component of the homeostasis, is a highly complex process that involves 
signaling between the periphery and the central nervous system. Our current understanding of 
feeding control stems from two major hypotheses.  The first one was proposed by Kennedy in 
1950’s, suggesting that proportional to the body fat content, inhibitory signals (also known as 
adiposity signals) are generated that act on the brain to reduce food intake105. Pancreatic 
hormone insulin, and adipocyte hormone leptin, are the two molecules identified as adiposity 
signaling candidates so far106. The effects of these hormones on the brain are shown to be 
mediated by distinct neuronal subpopulations and several regulatory neuropeptides in the 
hypothalamus106. In rats, microinjection of leptin into arcuate nucleus of hypothalamus was 
shown to inhibit food intake and reduce body weight, whereas arcuate-lesioned animals were 
not responsive to leptin treatment107,108. The second hypothesis was put forward in 1970’s by 
Gibbs and Smith proposing that during each meal, the digestive tract produces signals that 
communicate to the brain to terminate the meal109. These signals, known as satiety signals, 
include information from the taste buds in the oral cavity110, mechanical responses of 
stomach and small intestine during digestion110, peptides secreted by the stomach or by 
enteroendocrine cells of the gut such as cholecystokinin (CCK)111, and information related to 
energy metabolism in the liver112. The hindbrain and specifically nucleus tractus solitaries 
seem to be critical for the integration of the satiety signals which are received through the 
circulation, vagus nerve, and afferent nerves passing through the spinal cord from the 
gastrointestinal tract110,111,113. Nucleus tractus solitaries is also innervated by descending 
hypothalamic input.  
Mounting evidence suggest that brain circuits other than the ones involved in hunger/satiety 
pathways might contribute to the regulation of food consumption and energy homeostasis. 
This includes brain circuits implicated in the reward aspects of food. Various limbic regions 
(nucleus accumbens, hippocampus, and amygdala), cortical areas (orbitofrontal cortex, 
insula, and cingulate gyrus) and neurotransmitters (dopamine, serotonin, opioids and 
cannabinoids) are involved in orchestrating the rewarding effects of food114. Dopamine is the 
most-studied and best-characterized neurotransmitter in the context of reward mechanism, 
especially dopamine projections from ventral tegmental area into the nucleus accumbens115. 
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Research in experimental models suggest that disruption in dopamine synthesis, either 
pharmacologically or genetically, can cause profound alterations in feeding behavior116,117. 
Furthermore, dopamine plays an essential role in reinforcement of food-seeking behavior118–
120, and can be modulated by food availability cues and appetite-related hormones121. 
1.4.1 Anorexia nervosa and regulation of energy homeostasis and feeding 
Anorexia nervosa is a complex eating disorder characterized by extreme preoccupation with 
dieting, significantly low body weight, and intense fear of weight gain122. Anorexia is sex- 
and age-linked, and adolescent females are the most affected group. Nevertheless, the disease 
also affects males and other age groups122,123. Two subtypes of anorexia have been identified: 
the restrictive subtype marked by restricted energy intake, and the binge-eating/purging 
subtype which engage in recurrent episodes of  binge-eating and purging122. 
Anorexia is often accompanied by severe neuropsychiatric symptoms including depression, 
anxiety and obsessive-compulsive disorder124–126.As the disease progresses, anorectic patients 
exhibit various clinical complications including hypothermia, physical hyper-activity, and 
systemic endocrine deregulation such as impaired hypothalamic-pituitary-adrenal (HPA) axis 
and altered appetite-regulating hormone levels127,128. These complications are suggested to be 
adaptive responses to chronic starvation128–130, however, they might further contribute to the 
development and maintenance of the disease. Although eating normalization is shown to 
improve the weight gain in anorexic patients, still little is known about the etiology of the 
disease.  
As mentioned earlier, the hypothalamus has received significant attention in the context of 
feeding behavior regulation. However, evidence suggesting a critical role for the 
hypothalamic peptides in the neurobiology of anorexia is limited131. Progress in brain 
imaging techniques has led to the recognition of other involved neural circuits132,133. 
Dysfunction in these circuits are related to altered dopamine and serotonin metabolism. Brain 
fMRI scans from anorectic patients indicate elevated activity of the nucleus accumbens, a 
brain region densely innervated by dopaminergic neurons134–136. The dopamine system, and 
especially the projections to nucleus accumbens, are implicated in many brain functions that 
may be affected in anorexia nervosa including reward, punishment, satiety, habit formation 
and addiction137.  
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1.4.2 Gut microbiota in anorexia nervosa 
The gut microbiota is recognized as an important modulator of the host metabolism138–141 and 
appetite55. Various mechanisms have been proposed for the functional impact of gut 
microbiota on host metabolism including promotion of energy harvest capacity from the diet, 
modulation of polysaccharides and bile acid metabolism through microbial enzymatic 
activities, and enhancement of triglyceride production and transport142,143. Furthermore, 
following nutrient provision, bacterial peptides can stimulate hypothalamic pro-
opiomelanocortin (POMC) expressing neurons directly and/or through stimulation of gut 
hormones, and thus can regulate host satiety55. Moreover, accumulating data suggest that 
behavior and brain neurochemistry can be influenced by gut microbiota37,144. In the absence 
of gut microbes, mice show elevated turn-over of neurotransmitters, including dopamine, 
noradrenaline, and serotonin, as well as reduced expression of genes related to synaptic 
transmission144.  In mice devoid of gut microbes, strain-dependent alterations in anxiety-like 
behavior and locomotor activity have been reported45,64,144–147. Interestingly, there is evidence 
that the gut microbiota can influence the reward-mediating systems of the host. Depletion of 
gut microbiota enhances the sensitivity to cocaine reward and locomotor sensitization to 
repeated dose of cocaine148, and a study in ADHD patients shows that alterations in the gut 
microbiota is associated with reduced ventral striatal responses measured by fMRI during 
reward anticipation149.  
So far, few studies have reported dysbiotic gut microbiota in anorectic patients. Using a 
culture-based approach, 19 previously unknown species were identified from a single 
anorexia patient150. More in-depth culture-independent studies suggest that fecal microbiota 
diversity in patients with anorexia is reduced compared to healthy controls.151,152 Notably, 
levels of depression and anxiety were shown to be associated with composition and diversity 
of the intestinal microbiota151. In another study comparing the fecal profiles of obese, 
anorectic and normal individuals, anorectic patients displayed elevated levels of the archaeon 
Methanobrevibacter smithii which is associated with efficient microbial fermentation and 
increased energy yield153. The levels of mucin-degraders Verrucomicrobia and Bifidobacteria 
were also reported to be increased in anorectic patients in comparison with normal weight 
participants. It was previously shown that the abundance of Akkermansia muciniphila, a 
mucin-degrader bacterium, is inversely correlated to body weight154,155. Furthermore, 
anorectic patients exhibited reduced levels of Roseburia spp., a SCFA producing subspecies. 
After weight gain, microbial diversity was increased but the perturbations in the intestinal 
microbiota, SCFA profile and several gut symptoms were not improvd156. Whether the 
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alterations in the gut microbiota of anorectic patients precede the onset of symptoms or they 
appear during the illness as secondary effects is not known. Nevertheless, calorie 
restriction157 and endurance exercise158,159 were shown to modulate the diversity and 
composition of gut microbes, therefore dieting and excessive exercise in anorectic patients 
could leave their imprints on the gut microbiota.   
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2 AIMS 
Inspired by what is known about the ability of the gut microbiota to modulate tissue barriers 
and based on the existence of a gut microbita-brain axis, we aimed to identify the potential 
role of gut microbiota on CNS regulation of local and systemic homeostasis. The specific 
aims of each paper were: 
Paper I: To assess the influence of gut microbiota on intrauterine development of the BBB 
as well as on its integrity and function during adulthood using germ-free mouse model.  
Paper II: To characterize the BBB in a porcine model of preterm birth for further 
investigation of potential beneficial effects of microbiota and diet interventions on brain 
development and maturation under preterm conditions. 
Paper III: To investigate the relevance of gut microbiota for physiological, behavioral, and 
neurochemical phenotype in anorexia nervosa. 
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3 METHODOLOGICAL HIGHLIGHTS 
 
3.1 ANIMAL MODELS 
3.1.1 Germ-free or axenic mice 
 “Germ-free” or “axenic” mice are microbiologically sterile animals (as determined within 
the limitations of the available detection methods) that are raised in isolators under very strict 
handling procedures. The use of germ-free animals is a valuable approach which allows for 
investigation of microbe-microbe and microbe-host interactions. Germ-free animals can be 
selectively colonized by one or more bacterial species. Once inoculated with known 
microbial population the animals are referred to as “gnotobiotic”. “Gnotobiotic” is derived 
from the greek “gnotos” (known), and “bios” (life). The terms “germ-free” and “gnotobiotic” 
are sometimes used interchangeably. 
In project I, we used germ-free mice obtained from Core Facility for Germ Free Research 
(CFGR) at Karolinska Institutet. All animals had ad libitum access to autoclaved R36 
Lactamin chow and sterile water and maintained under 12h light/dark cycles. As controls, 
specific-pathogen-free (SPF) adult mice were used. The SPF mice possess commensal 
bacteria but are free from known pathogens that causes clinical and subclinical infections160. 
The SPF mice are regularly screened for pathogens (3 or 4 times a year) as recommended by 
Federation of Laboratory Animal Science Associations. In order to confirm that the 
alterations observed in our experiment were mediated by microbiota and/or microbial 
metabolites we conventionalized (CONV) a group of germ-free adult mice with fecal samples 
from the SPF mice. Another group was treated with bacterial strains that produce SCFAs, and 
a third group recieved the sodium salt of butyrate.  
 
Emergence of germ-free animals 
In 1885, Louis Pasteur proposed that animals devoid of bacteria would not be able to 
survive161, pointing out to the importance of the symbiosis between the microbes and the 
host. About ten years later, for the first time, Nuttall and Thierfelder reported successful 
rearing of germ-free derived guinea pigs for more than one week162. Today, thanks to the 
advances of germ-free technology, we know if proper environmental conditions are provided, 
animals could survive in the absence of co-habiting microbes, albeit with certain 
physiological and behavioral alterations161. Germ-free technology flourished about a century 
after the generation of the first germ-free mammals through the work of three independent 
research groups. James Reyniers and the coworkers at the University of Notre Dame were the 
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pioneers to generate germ-free rodents163. In parallel, a group led by Bengt Gustafsson at 
Lund University in Sweden began a germ-free research program and succeeded to design 
novel stainless steel germ-free rearing isolators (Fig. 3)164. The third group was headed by 
Masasumi Miyakawa at the University of Nagoya in Japan165.  
 
 
Figure 3. Gustafsson’s stainless steel germ-free isolator. (A) Exterior of germ-free isolator. (B) 
Cross-section of germ-free isolator. L. lighting frame, J. air sterilizer, W. water tank, P. water pump, C. 
cages, G. glove ports, F. food canisters, T. Food autoclave and transfer unit. Adopted from 
Gustafsson BE, Ann N Y Acad Sci, 1959. Copyright 2006. With permission from Wiley Publications. 
 
Derivation and maintenance of germ-free animals 
The methodological approach to derive germ-free or axenic animals has not been changed 
drastically since the generation of the first germ-free rodents by Reyniers. In order to 
initiate the first colony, the pups are delivered by C-section in a sterile manner to avoid 
acquisition of microbes from the environment, mother’s vagina or mother’s skin. Following 
birth, the pups are transferred into sterile isolators and hand-reared158–160. Thereafter, the 
next colonies could be interbred and born inside the isolators. An alternative method is to 
transfer embryos at 2-cell stage into pseudo-pregnant germ-free recipients. This method 
eliminates contaminations associated with vertical transmission in C-section method161,162. 
The germ-free mice receive sterile food and water. Any other material that is brought into 
the isolators including bedding and experimental tools should be devoid of microbes. The 
cages are regularly swabbed and the feces samples are analyzed to assure that the animals 
remain germ-free inside the isolators157–160.  
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Characteristics of germ-free mice 
Germ-free mice deviates from conventional mice in various anatomical, physiological and 
behavioral aspects. Some of the characteristics of germ-free mice are summarized in Table 1. 
 
Table 1. Characteristics of germ-free mice 
No.  Category Phenotype 
1 
Anatomy 
Enlarged cecum166 
Smaller heart, liver, and lungs167 
2 
Intestinal morphology  
Thinner intestinal wall168 
Decreased number of villi167 
Fewer and smaller Peyer’s patches168 
Thinner mucus layer169 
Fewer number of goblet cells168 
3 
Enteric neural network  
Reduced myenteric neurons170,171 
Decreased enteric neural network170,171 
4 
Metabolism  
Decreased basal metabolic rate, body fat percentage, circulating 
levels of adiposity hormones and glucose142 
Resistance to diet-induced obesity172,173 
5 
Behavior 
Strain-specific alterations in anxiety-like behavior45,64,144–147 
Strain-specific alterations in locomotor activity144,146 
Contradictory data on social preference145,174 
6 
Central neurochemical 
changes 
Elevated turn-over of monoamine neurotransmitters in striatum144 
Region-specific alterations in BDNF transcription144,175  
7 
Immune system Impaired development of gut-associated lymphoid tissues176,177 
Defective antibody production168 
Deficient expression of antimicrobial proteins168 
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One of the anatomical hallmarks of the germ-free mice is the enlarged cecum (Fig. 4). The 
cecum in germ-free mice contains considerably higher amount of liquid content166,178. Cecum 
enlargement has been associated to osmosis caused by accumulation of dietary fibers, 
undegraded mucus, and sulfate-containing glycoproteins.  
 
Figure 4. Enlarged cecum in germ-free mice. (A) Representative macroscopic illustration and (B) 
weight measurement of the cecum in germ-free (GF) mice in comparison to specific pathogen-free 
(SPF) controls. n= 12, **** P< 0.0001, Error bar represents S.E.M. 
 
Limitations of germ-free animals 
Similar to any other experimental tool, germ-free model systems are required to be 
thoroughly understood to be able to use them for suitable purposes. Notably, the conditions 
inside the sterile isolators in which laboratory germ-free animals are bred and maintained are 
far from the conditions in the outside world where animals (and human) have intimate 
relationship with environmental microorganisms as well as with their own resident microbes. 
Rare exceptions were two patients maintained in sterile hospital rooms due to severely 
compromised immune system: David Vetter who became known as the “bubble boy” (Fig. 
5), and Ted DeVita179,180. An alternative method to germ-free animals, is the use of antibiotics 
to deplete the gut microbiota. However, antibiotic treatment has its own limitations as some 
antibiotics could confer direct effects on the host. 
Another limitation of working with germ-free animals is that it burdensome to perform 
procedures that require a lot of handling or specific tools inside the isolators. Usually, such 
procedures should be planned at the end of the experiment when the animals could be taken 
out of the isolators. Despite the limitations, germ-free animals are proven to be valuable 
experimental models to investigate microbe-host interactions and contributed enormously to 
the knowledge we have today about the cross-talk between the microbes and the host. 
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Figure 5. The boy who was raised inside an isolator. (A) David Vetter (left) and immunologist 
Rafael Wilson (right) who created the isolator to keep the newborn germfree until bone-marrow 
transplantation could be performed. Photo: Courtesy Baylor College of Medicin Archives. (B) public 
recognition of the “bubble boy” in a movie directed by Randal Kleiser (1976). 
 
3.1.2 Porcine model of preterm birth 
In paper II, we took a step forward into an experimental animal model, which in comparison 
to rodents, shows greater physiological and developmental similarities to human. Pigs are 
monogastric animals and have a digestive system that highly resembles to human. Therefore, 
they are widely accepted as model for nutritional and gastrointestinal studies. Moreover, pig 
brain is convoluted, and has higher connectivity and complexity compared the lissencephalic 
brain in rodents. Another advantage of the pig model is that due to their larger body size 
compared to rodents, it is relatively easy to handle and perform surgical experimentations on 
them. Collectively, these properties make pig a translational model for our study concerning 
BBB maturation under preterm condition and in response to early feeding.   
Our preterm pigs were delivered at 90% of gestation (day 106) by caesarean section. A group 
of animals were sacrificed within eight hours after birth, and another group was reared for 
five days at the Neonatal Pig Research Center, Copenhagen University. Compared to term 
piglets, these animals display signs of immaturity in different organs. Due to respiratory 
distress, enteral food intolerance, impaired thermoregulation, and poor locomotion, preterm 
piglets need to be housed in intensive care units181.  Similar to preterm infants, preterm 
piglets spontaneously develop microbiota- and diet-associated disease i.e. necrotizing 
enterocolitis (NEC)182. Previous investigations of the luminal bacteria indicated that gut 
A B 
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colonization in preterm piglets is distinct compared to the term controls and is marked by 
decreased abundance of Lactobacilli spp.183 
 
Parenteral and enteral feeding 
Infants who survive NEC were shown to have higher risk for neurodevelopmental 
impairments184–186. Previous studies suggest that enteral feeding with infant formula 
predisposes to NEC in human preterm infants33,187, as well as in preterm pigs182, whereas 
early gradual feeding with bovine colostrum is protective against NEC in preterm piglets188. 
To assess the potential effects of feeding on the development of the brain barriers in preterm 
pigs, we divided the animals into two groups: one received total parenteral nutrition (PAR, n 
= 10 per group) through vascular catheters (4Fr, Portex) in the umbilical cord, and the other 
group received enteral feeding via orogastric tubes (6Fr, Portex, Kent, UK) + supplementary 
parenteral nutrition (ENT, n = 10 per group). The PAR groups received 96 ml/k/d of 
modified Kabiven intraarterially (Fresenius-Kabi, Bad Homburg, Germany) on day 1 
increasing to 144 ml/kg/d on day 5. The ENT groups received 16 ml/kg/d of intragastric 
bovine colostrum (Biofiber Damino, Gesten, Denmark) on day 1 slowly increasing to 64 
ml/kg/d on day 5 with decreasing supplements of intra-arterial Kabiven to ensure total 
isoenergetic levels throughout the five days. In another experiment, the animals were fitted 
with vascular catheters and oragastric feeding tubes. Enteral feeding over the first five days 
after birth consisted of rapidly increasing volumes of infant formula, containing maltodextrin 
as a main carbohydrate source. The first 48 h, pigs were fed 24-48 ml/kg/d of enteral nutrition 
+ 32-48 ml/kg/d of intra-arterial Kabiven (Fresenius-Kabi). Subsequently, parenteral nutrition 
was discontinued and piglets were fed increased volumes of enteral nutrition (80-120 
ml/kg/d) until euthanasia.  
 
Limitations of porcine models of preterm birth 
Long gestational period in pigs is a limiting factor for the design of the experiments. Full 
term gestation takes 117 days in Danish production herds. In case of preterm pigs, due to 
immaturity, a lot of care and a dedicated facility is required during the first days following 
birth. This includes transfer into oxygenated and thermo-regulated incubators, activity 
monitoring, and fitting umbilical catheters and orogastric tubes for feeding.  
Previous observations have led to the estimation that preterm piglets delivered at 90% 
gestation correspond to preterm infants born at 75% gestation189. However, this estimation is 
based on gastrointestinal characteristics and do not apply to other tissues such as the brain. In 
fact, the brain in preterm piglets is more mature relative to preterm human infants181. 
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Therefore, the interpretation of the results in neurodevelopmental studies in preterm piglets 
should be made with careful consideration.   
3.1.3 Human fecal microbiota-transplanted mice 
In animals, the use of germ-free rodents has largely contributed to unraveling the causality of 
microbiota in certain diseases. However in human, microbiota research is mainly limited to 
studies of alterations in diversity and composition which only illustrate correlations rather 
than causality. To tackle this problem, human microbiota-transplanted (HMT) mice are being 
used more commonly. The HMT mice are obtained through transplantation of human fecal 
microbiota into germ-free or antibiotic-treated mice (with depleted gut microbiota). Whether 
features of pathophysiological phenotype observed in the donor could be recapitulated in the 
recipient mice is then investigated in comparison to mice inoculated with microbiota from 
healthy controls. Analysis of human microbiota before and after the transplantation indicates 
that approximately 85% of the microbiota at the genus level could be successfully transferred 
into the recipient mice190. Furthermore, various studies have reported that behavioral and 
pathophysiological phenotype of the human donor could be reproduced in the recipient mice 
through microbiota transplantation. This includes obesity138, childhood asthma191, and 
pregnancy metabolic syndrome192. Gordon and coworkers were pioneers in using microbiota 
transplantation method in combination with dietary regimens to understand the role of the gut 
microbiota in defining the host’s nutritional status, especially under conditions such as 
obesity and under-nutrition which impose considerable burden on global health. In their 
approach, they inoculate germ-free mice with microbiota collected from the donors sharing 
the characteristics of interest, and feed them with the diet consumed by the corresponding 
donor or derivatives of those diets. The features of the donor’s phenotype that could be 
transmitted are then investigated and the metabolic and signaling networks as wells as the 
effect of dietary regimens on microbe-host and microbe-microbe interactions are 
identified138,139.  
In paper III we used HMT mice to investigate the relevance of gut microbiota for disease 
phenotype associated with anorexia nervosa. We transplanted fecal microbiota from one 
anorectic patient and one healthy control into germ-free mice by oral gavage. Following fecal 
transplantation, we housed the two groups in separate isolators for 10 weeks. During this 
period we monitored food intake and weight gain. At the end of the experiment we assessed 
anxiety-like behavior and locomotion with open-field test. Afterwards, different tissues were 
harvested and stored for analysis.  
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Limitations of HMT mice 
When working with HMT mice, it should be considered that microbiota transplantation from 
human individuals, only captures a snapshot of the microbiota in a fixed point of time under 
certain conditions.  This snapshot can be possibly affected by various factors such as diet, 
antibiotic treatment, and age of the subject, as well as sampling and storage methods193, 
which can complicate the interpretation of the outcomes. Therefore, careful consideration 
should be given in terms of potential confounding factors.  
Moreover, the coevolution of the mammalian host and the microbiota favors genetic and 
physiologic adaptations that maximize the efficiency of the symbiotic relationship and leads 
to development of host-specific microbial communities and mechanisms 194–197. An example 
of such mechanisms is the ability of the bacteria to form epithelial biofilm which is strictly 
dependent on the host origin. Monocolonization of the mice with strains of L. reuteri only 
induces epithelial adherence and biofilm formation if the strain is isolated from murine 
host194. Moreover, metagenome analysis comparing human and murine microbiome suggest 
that they only share ~10% of the microbiome at genus level and 14.2% at species level198. 
Germ-free mice colonized with human microbiota exhibit lower levels of innate immune 
cells, declined expression of antimicrobial peptides, and overall less mature intestinal 
immune response relative to germ-free mice colonized with murine microbiota196.  
Despite the substantial differences between human and mice microbiota at species level, they 
still share great similarities at higher taxonomic levels with Firmicutes, Bacteroidetes, and 
Proteobacteria being the predominant phyla in both hosts.198,199. In addition, the 20 most 
abundant core bacterial genera in mice, shows 65% similarity to that of human198 (Fig 6).  
Therefore, despite the limitations of the HMT mice, this model can still serve as one of the 
best models to study dybiosis-associated diseases.   
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Figure 6. Top 20 core bacterial genera in mouse and human microbiota. Adopted from Xiao et 
al., Nature Biotechnolog, 2015. Copyright 2015. With permission from Wiley Publications. 
 
3.2 PERMEABILITY ASSESSMENT OF THE BRAIN BARRIERS 
In Paper I, we used three different methods to assess BBB permeability in germ-free mice 
compared to mice with normal flora: (i) Evans blue perfusion, (ii) Positron emission 
tomography imaging with [11C] raclopride, and R4A antibody injection. In paper II, we 
assessed blood-CSF barrier permeability by measuring CSF:blood ratio of endogenous 
protein (albumin) and an exogenous tracer (raffinose).  
 
Evans blue perfusion 
Evans blue is a an azo dye with high affinity for serum albumin and is commonly used as a 
chemically inert tracer for the assessment of BBB permeability. It fluoresces with excitation 
peaks at 470 and 540 nm and an emission peak at 680 nm. Extravasation of Evans blue into 
brain parenchyma is thought to reflect albumin leakage and increased BBB permeability. 
Albumin has a high molecular weight (66.5 KDa) and is poorly transported cross the BBB 
under physiological conditions. Evans blue perfusion is a reliable and inexpensive method to 
visualize disruption in the BBB and it has been used since the discovery of BBB by Ehlrich 
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and Goldmann. We utilized this method with a controlled perfusion rate to avoid damaging 
the capillaries.  
 
Positron emission tomography (PET) imaging with [11C]raclopride  
Raclopride is a synthetic compound that acts on dopamine D2 receptors as an antagonist. 
Radiolabelled raclopride is used in in vivo PET imaging, primarily for the assessment of 
binding capacity of dopamine D2 receptors, useful for diagnosis of movement disorders. But 
here, we used raclopride as a tracer to assess BBB permeability. Following intravenous 
injection of the tracer, we measured the regional tissue radioactivity concentrations. 
Concentrations in the initial flow phase represent the presence of the radioligand in the whole 
brain due to BBB permeability as opposed to concentrations in the later phase of the activity 
curve which indicate binding capacity to dopamine D2 receptors. 
 
R4A antibody 
R4A is an anti-DNA antibody which cross-reacts with N-methyl D-aspartate receptor 
(NMDAR) and mediate neuronal death only if the BBB is breached200,201. We assessed the 
morphology and number of neurons in the hippocampus following intravenous injection of 
R4A to germ-free versus specific-pathogen free mice.  
 
CSF:blood raffinose 
Raffinose is a small (504 Da) hydrophobic plant trisaccharide. Since human and monogastric 
animals including pigs do not possess the enzyme (α-galactosidase) to breakdown raffinose, 
we used it as an inert tracer to measure blood-CSF barrier permeability in pigs. Raffinose 
concentrations in collected plasma and CSF samples were quantified by liquid 
chromatography tandem mass spectrometry.  
3.3 MICROARRAY 
Microarray is a robust and reproducible high through-put method for detecting relative gene 
expression levels. In this method, mRNA molecules isolated from both experimental and 
control samples are reverse-transcribed into complementary DNA (cDNA) and differentially 
labeled with fluorescent dyes. The samples are then applied to a DNA chip which contains 
large number of DNA hybridization probes at defined positions. Following the hybridization 
step, the chip is scanned to measure the expression of each gene. We used Mouse Gene 2.1 
ST Array Plate (Affymetrix, 902140) to compare expression profiles between mice harboring 
anorexic microbiota and mice transplanted with healthy microbiota in micro-dissected 
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nucleus accumbens and hippocampus samples. Following RNA isolation, Agilent RNA 
ScreenTape assay in combination with the 4200 TapeStation system was used for quality 
control. Raw data were processed in Affymetrix Expression Console software (v.1.4.1) using 
the RMA analysis method. The data was then transferred to Qlucore Omics Explorer 3.3 
(Qlucore AB, Lund, Sweden) for further analysis. Heatmaps and PCA plots were generated 
following statistical filtering.  
Despite the comprehensive sequencing information derived by microarray analysis, this 
method cannot be used for detection of structural variations and isoforms, and discovery of 
novel transcripts, because the design of the hybridization probes is based on prior sequencing 
knowledge. Nevertheless, it is a cost-efficient and widely-used method, suitable for 
comparative gene expression.  
Figure 7. Schematic illustration of microarray workflow. 
 
 
 
 
RNA Isolation cDNA Synthesis 
& Labeling
Hybridization 
ScanningClustering Analysis
Gene Set
 Enrichment
Pathway or 
Network analysis
Healthy-GF
Anorexia-GF
Brain 
Microdissection
 34 
4 RESULTS AND REFLECTIONS 
More detailed description of the results of each study can be found in the respective 
article/manuscript. Here, the main findings are presented briefly. 
4.1 Maternal gut microbiota mediates intrauterine development of blood-
brain barrier 
Previous observations suggest that the gut microbiota modulates barrier permeability and 
function in the intestines98,101 and in testis103, but the putative effects on the BBB were not 
investigated. In paper I, we assessed the impact of gut microbiota on the development and 
function of the BBB, using the germ-free mouse model. The development and maturation of 
the BBB begins during intrauterine stage and continues progressively into early postnatal 
period82. Based on the evidence that the fetus is exposed to maternal microbiota and 
microbial metabolites15,16, we explored the impact of maternal gut microbiota on fetal BBB 
development. We injected an immunoglobulin G2b (IgG2b) antibody labeled with infrared 
dye into dams during timed pregnancies and measured the presence of the antibody in the 
brains of the embryos. First, we showed that in embryos of dams with normal gut flora, 
starting around E15.5-E17.5, the antibody was confined to the developing vasculature and did 
not penetrate into the brain parenchyma. This was in agreement with previous observations 
showing that BBB becomes functional during the late stage of intrauterine life84,88. In 
contrast, the antibody was diffused into brain parenchyma in E16.5 embryos of germ-free 
dams. Furthermore, expression of tight junction protein occludin was significantly lower in 
germ-free embryos compared to controls. Our results suggest that coinciding with increased 
nutritional demand in late pregnancy, maternal gut microbiota contributes to the maturation 
of an intact BBB in order to strictly control molecular trafficking to the brain in the 
developing offspring.  
4.2 Gut microbiota influences blood-brain barrier functional permeability and 
expression of tight junction proteins in adult mice 
In order to assess whether impairment of BBB in the absence of gut microbiota persists into 
adulthood, we measured BBB permeability in adult germ-free mice in comparison to mice 
with normal flora. Using Evans blue technique, we showed increased BBB permeability in 
hippocampus, striatum, and prefrontal cortex of germ-free mice, indicated by penetration of 
Evans blue into the parenchyma. The increased BBB permeability was also displayed as 
elevated [11C] raclopride uptake in the brain by in vivo PET imaging, and increased neuronal 
death caused by penetration of intravenously injected R4A antibody. We next investigated 
the expression and topography of BBB tight junction proteins by western blot, 
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immunofluorescence staining, and transmission electron microscopy in our animal model. 
Our data indicated that the increased BBB permeability in germ-free mice was accompanied 
by disruption in occludin and claudin-5.  
To confirm whether the alterations observed in BBB are mediated by the gut microbiota and 
bacterial products, we introduced either active or heat-inactivated fecal microbiota into the 
germ-free mice through a single oral gavage. The mice were left for 14 days before being 
sacrificed. Then, we assessed albumin leakage into parenchyma following Evans blue 
permeability test. The active microbiota induced reduction in the BBB permeability, whereas 
Evans blue could still be detected in the brain parenchyma of the recipients of inactive flora 
(Fig. 8). Moncolonization of the germ-free mice with bacteria known to produce SCFAs or 
treatment with butyrate salt, one of the three SCFAs, also induced effects similar to 
colonization with active flora. SCFAs were previously shown to enhance the integrity of  
intestinal epithelial barrier202,203.  
 
Figure 8. Colonization of germ-free mice with active flora alleviates impaired BBB permeability. 
Representative images of Evans blue dye (shown in red) in the prefrontal cortices of germ-free (GF), 
GF colonized with heat-inactivated microbiota (GF + Inactive Flora), GF colonized with active flora, 
and pathogen free (PF) mice. Cell nuclei were stained with DAPI (shown in blue). Scale bars, 50 µm.  
 
4.3 Preterm birth is associated with structural and functional deficits of 
developing brain barriers in pigs 
Preterm birth is associated with impaired development and maturation of many organs 
including the brain204. During the critical early postnatal period, normal brain growth and 
maturation may be negatively affected by the prematurity-related factors such as nutrient 
deprivation or a serious infection205. In paper II, we used a preterm porcine model to study 
the effects of gestational age, early feeding, and infection on brain barriers following preterm 
birth. First, to characterize BBB structure in our model, we investigated BBB molecular and 
cellular components. Our protein analysis data indicated that, at birth, BBB-associated 
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proteins including occludin, ZO-1, VE-cadherin, GLUT-1 and MCT-1 were differentially 
regulated in striatum and hippocampus of preterm piglets compared to term controls.  
Astroglial end-feet provides structural support to the endothelial cells. We analyzed the 
astrocyte perivascular coverage by measuring the percentage of overlap between astrocytes 
(stained with anti-GFAP antibody) and blood vessels (stained with anti-laminin antibody) in 
microscopic images (Fig. 9A). Our data indicate that astrocyte-vessel overlap was 
approximately 10% decreased (p <0.0001, Fig. 9B) in the hippocampus (not in striatum) of 
preterm piglets relative to term controls. The decreased astroglial perivascular coverage was 
not due to differences in capillary density as the laminin-stained areas were similar among the 
groups (data not shown). In agreement with the immunofluorescent staining data, western 
blot analysis of auqaporin-4 (AQP-4), a water channel protein which is highly expressed by 
astrocyte end-feet206, indicated decreased protein expression in the hippocampus of preterm 
piglets (P<0.05, Fig.9 C-D).  
 
 
Figure 9. Decreased astroglial perivascular coverage in the hippocampus of preterm piglets. 
(A) Representative images of astrocyte (GFAP, red) and blood vessel (laminin, green) co-stained 
hippocampal coronal tissue sections from preterm and term newborn pigs.(B) Quantification of GFAP 
and laminin overlay as a measure of perivascular astrocyte coverage (n = 5–10 per group). (C) 
Representative Western blots and (D) densitometric quantifications of AQP-4 and GFAP in the 
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hippocampus of preterm and term newborn pigs (n = 5–10 per group). Values are normalized to the 
reference protein β-tubulin. Mean term levels are assigned a value of 1 and preterm levels scaled 
accordingly. All data are presented as means with standard errors. * p < 0.05, **** p < 0.0001. 
Modified from paper II. Copyright 2018. With permission from S. Karger AG, Basel. 
 
We then assessed blood-CSF barrier permeability by measuring CSF-plasma ratio of albumin 
as well as CSF-plasma ratio of raffinose following intra-arterial administration of 5 mL/Kg 
body weight of raffinose. Preterm piglets displayed elevated albumin and raffinose ratios 
compared to term controls suggesting increased nonselective transcellular transport across 
blood-CSF barrier.  
Collectively, these data suggest that there is a deficit in the brain barriers following preterm 
birth which might enhance the vulnerability of the developing brain to inflammation and 
nutrient deprivation associated with preterm birth. One of the severe complications of preterm 
birth is necrotizing enterocolitis (NEC, inflammation in the intestines) which affects up to 7% 
of preterm infants207. The onset of the disease is in part due to enhanced reactivity of the 
premature intestinal mucosa to microbial colonization during the first days following birth33. 
Notably, the survivors of the NEC display an increased risk of neurodevelopmental 
impairments184–186.  
In an independent experiment, we fed preterm-born piglets with infant formula for five days. 
Formula feeding was previously shown to predispose to NEC in human preterm infants33,187 
as well as in preterm pigs182. We evaluated NEC-like lesions in harvested colon and intestine 
samples and divided the animals into three groups based on their NEC scores (Fig. 10): 1. 
Healthy (highest NEC score 1–2, n = 49), 2. Moderate NEC (highest score 3–4, n = 39), or 3. 
Severe NEC (highest NEC score 5–6, n = 43). Assessment of the inflammatory markers in 
the intestinal tissue and in circulation showed that sever NEC is associated with local and 
systemic inflammation. The levels of IL-8 in the small intestine and IL-6 in the plasma were 
significantly increased in piglets with sever NEC compared to unaffected counterparts. 
We then evaluated blood-CSF barrier permeability by measuring CSF-plasma ratio of 
albumin and raffinose. Our data indicated that NEC severity is associated with increased 
blood-CSF barrier permeability. Furthermore, with histopathalogical analysis, we identified a 
characteristic pattern of pyramidal neuron degeneration in the hilus and CA regions of the 
hippocampus in piglets with sever NEC. We also showed increased IL-6 levels in the 
hippocampus in line with the elevated levels in the circulation. Taken together, we propose 
 38 
that sever NEC in preterm piglets is associated with brain barrier dysfunction, inflammation 
and neural damage. Interestingly, in another experiment, we showed that in the absence of 
NEC, preterm piglets treated with either partial enteral or total parenteral nutrition for five 
days had normalized expression levels of endothelial tight junctions (except ZO-1) and 
transport proteins compared to the term controls, while the astroglial perivascular support 
remained lower in the hippocampus of preterm pigs.  
 
 
Figure 10. NEC lesion evaluation in formula-fed preterm piglets. (A) Representative necropsy 
pictures of small intestine and colon in animals with No (score 1-2), moderate (score 3-4), or sever 
(score 5-6) NEC lesions (upper). Scoring system consists of 6 grades of increasing pathology (lower). 
(B) Proportion of pigs with NEC distributed by lesion severity across gut segments and accumulated 
(n = 39–49 per group). Modified from paper II. Copyright 2018. With permission from S. Karger AG, 
Basel. 
 
4.4 Microbiota transplantation from an anorectic individual induces anorexia-
like symptoms in germ-free recipient mice  
The gut microbiota is capable of secreting or modulating the production of molecules that 
affect both energy balance and energy stores142,173,175,208. Most of the studies that have 
investigated the role of gut microbiota in the context of energy homeostasis and metabolism 
have focused on obesity and diabetes, probably due to the profound and pervasive effects of 
these conditions on global health. Other diseases with altered metabolism and homeostatic 
function have received less attention. In paper III, in order to explore the impact of gut 
microbiota on host homeostasis on a systemic level, we focused on anorexia nervosa, a 
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serious eating disorder characterized by restricted energy intake, significantly low body 
weight, fear of gaining weight, and distorted perception of one’s body. Microbiota dysbiosis 
has been documented in anorectic patients150–153,156. In a pilot study, we transferred gut 
microbiota from an anorectic patient and a sex-matched healthy individual into germ-free 
mice (n=10 per group). Fecal microbiota transplantation was performed through a single oral 
gavage, and following the transplantation, animals were maintained in isolators for 10 weeks. 
During this period, body weight and food intake were recorded twice per week. At the end of 
10 weeks, mice were taken out of the isolators and an open-field test was performed. The 
mice were then sacrificed and various tissues were collected for further analysis.  
 
Figure 11. Changes in body weight, anxiety-like behavior and HPA axis. (A) Body weight gain 
was measured in mice harboring anorexic (AN-GF) versus healthy (H-GF) human gut microbiota over 
10 wk following fecal transplantation. All mice were given ad libitum access to food and water during 
the experiment. At week 10 post transplantation open-field test was performed for 5 min. (B) shows 
corticosterone  levels in the serum following the open field challenge. (C) displays schematic of zones 
in the open-field arena and representative traces of mouse movement during an open-field test. (D) 
illustrates the total time spent in the center of the arena. Statistical significance was measured by two-
way ANOVA with Sidak’s test for body weight measurements, and with t test for open-field test and 
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corticosterone quantification. n= 10; *P < 0.05. All error bars represent S.E.M.  
 
In line with what is known from anorectic patients, microbiota transfer resulted in reduced 
weight gain, substantial elevation in the corticosterone levels, as well as increased anxiety-
like behavior in recipient mice compared to mice with healthy microbiota (Fig. 11). Despite 
the decreased weight gain, no differences were observed in food intake, weight of visceral 
white adipose tissue, and circulating levels of leptin between the groups. This might be due to 
difference in efficiency of energy harvest between the anorectic and healthy microbiota. 
Previous studies suggest that gut microbiota play a critical role in energy harvest, storage and 
expenditure from the diet by mechanisms such as breaking down the SCFAs, stimulation of 
gut peptide production, affecting gut motility, and regulating the expression of angiopietin-
like 4 (ANGPTL4)209 which encodes a protein that is directly involved in regulating lipid 
metabolism. 
4.5 Gene transcription is altered in the nucleus accumbens of mice 
harboring anorexic microbiota  
Nucleus accumbens, an area densely innervated by dopaminergic neurons,  regulates many 
functions potentially affected in anorexia nervosa, including reward, punishment, satiety, 
habit formation and addiction134,136. Increased neuronal activity in nucleus accumbens have 
been reported in anorectic patients135. We performed microarray analysis on brain 
homogenates from mice harboring either anorectic or healthy microbiota. Our data indicated 
pronounced changes in gene expression in the nucleus accumbens, while very few transcripts 
were altered in the hippocampus. In total, 157 transcripts in nucleus accumbens were 
differentially expressed (P ≤ 0.01, -1.5 ≥ fold change ≥ 1.5). Next, we analyzed the genes that 
were either up- or down-regulated in the following selected pathways: feeding behavior, ion 
transport, synaptic transmission, inflammatory response, and temperature control. Of 
particular interest was the altered expression of melanocortin 2 receptor accessory protein 2 
(MRAP2), a metabolic regulator implicated in leptin-melanocortin pathway. Mice lacking a 
functional copy of MRAP2 develop sever obesity, and rare variants of MRAP2 may be 
associated with obesity in humans210. The role of MRAP2 in regulation of energy expenditure 
and food intake has been explained in the hypothalamus but its function in the nucleus 
accumbens has not been investigated.  
Interestingly, among all the selected pathways, the ion transport pathway had the highest 
number of altered genes in the nucleus accumbens. This might indicate a perturbed neuronal 
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function. It was shown that open-probability of ATP-dependent potassium channels of 
dopaminergic midbrain neurons is enhanced under food restriction and is associated with 
exploratory behavior, supporting the tie between starvation and motivational value134,211.   
 
Ingenuity Pathway Analysis (IPA) of the microarray data indicated that eleven canonical 
pathways were significantly altered, including pathways involved in appetite and body weight 
regulation such as cholecystokinin/gastrin-mediated signaling. Cholecystokinin (CCK) is the 
first gut peptide released during/after each meal to reduce food intake212 and was shown to be 
modulated by gut microbiota213. Obese rodents, which are known to have drastic changes in 
the gut microbiota, display reduced CCK signaling in the brain212,214. In addition, dopamine, 
serotonin, glutamate and catecholamine pathways were also affected in the nucleus 
accumbens of mice with anorectic microbiota, as shown in the IPA analysis. The impact of 
anorectic microbiome on the dopamine system was confirmed by qPCR and 
immunohistochemistry analysis showing elevated dopamine producing enzyme tyrosine 
hydroxylase in the nucleus accumbens.  
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5 CONCLUDING REMARKS AND PERSPECTIVE 
Traditionally, the view over the pathophysiology of neurological and psychiatric disorders 
was  a “germ-free” view. The observation that the parasite Toxoplasma gondii is able to 
hijack the brain mechanisms to alter the behavior in the rodent host in favor of its own 
reproduction215–217, provided a remarkable evidence for microbial modulation of brain 
function and behavior. Over a decade of research on microbial residents of the gut suggest 
that manipulation of host behavior and brain function is not limited to the parasites. The 
contribution of the gut microbiota to the basic developmental process of the CNS such as 
neurogenesis, myelination, and microglia maturation has been implicated46. However, the 
mechanisms underlying the gut microbiota-brain interaction remain to be further understood. 
In paper I, we showed that the gut microbiota mediates the development of the BBB and 
plays an important role for maintaining BBB integrity and function. Through 
monocolonization of germ-free mice with bacteria that produce SCFAs or treatment with 
sodium butyrate, we further proposed that bacterial metabolites are involved in the BBB 
modulation by gut microbiota. Our findings were confirmed in a later study where antibiotic 
treatment was used as a mean to deplete the gut microbiota. Fröhlch et al. showed that short-
term intragastric treatment of mice with a mix of non-absorbable antibiotics was associated 
with gut microbiota dysbiosis and altered protein expression of tight junctions in the 
hippocampus and amygdala. Antibiotic-treated mice displayed impaired novel object 
recognition memory and neurochemical changes including differential expression of  brain-
derived neurotrophic factor (BDNF) and serotonin transporter, alteration in neuropeptide Y 
(NPY) system, and changes in corticosterone levels218 which were previously reported in 
germ-free animals. We acknowledge that “all out” or single species colonization approaches 
do not address the complex interspecies cross-talk among different microbes and microbial 
sub-populations within the gut. Future studies investigating microbiota-derived impacts on 
the BBB by targeted manipulation of the gut microbiota could lead to discovery of novel 
therapeutic approaches for the treatment of neurological diseases with BBB impairments. 
Currently, strategies such as targeting quorum–sensing (a bacterial cell-cell communication 
process) and engineering phages (viruses that infect bacteria) in order to manipulate the gut 
microbiota are being increasingly explored219. With the advancement of synthetic biology 
smart microbes with novel functionalities could be developed.  For instance, engineered 
E.coli bacteria which overproduce interspecies quorum sensing molecule autoinducer-2 (AI-
2) was used in a study where dysbiosis of microbiota was induced by streptomycin treatment 
of the mice and was shown to rebalance the observed alteration in Firmicutes/Bacteroidetes 
ratio220.  
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An intact and functional BBB is specially important in the early postnatal period which 
coincides with microbial colonization and introduction of enteral feeding. This was supported 
by our observation in paper II that the impaired brain barrier integrity and function in preterm 
piglets with sever NEC, was associated with neuronal damage and increased levels of 
inflammatory cytokines in the brain. Deficiencies in brain barriers could potentially 
contribute to the increased susceptibility to neurodevelopmental diseases in preterm infants. 
In a way, the BBB functions as a double-edged sword. On the one hand, an intact BBB is 
favorable and required for normal neuronal function and development, and  on the other 
hand,  it is an obstacle for the drug delivery to the brain. In fact, the BBB is one of the main 
reasons behind the lack of effective treatments for the majority of the CNS diseases. Almost 
all the large-molecule drugs and most of small-molecule drugs (> 98%) are excluded by the 
BBB and only limited number of small lipophilic drugs with molecular mass below 400 Da 
may cross221. Despite the advancement in the strategies such as chemical modification of the 
drugs, use of drug vectors, “temporary” BBB disruption, transnasal and transcranial drug 
delivery to breach the BBB, it still remains a major bottleneck in neurotherapeutics. 
Understanding the mechanisms behind microbiota-mediated modulation of the BBB could be 
beneficial for the development of new BBB delivery solutions. 
Previous investigations of the impact of gut microbiota on brain mechanisms involved in 
regulation of energy homeostasis have proposed alterations in the hypothalamus and brain 
stem gene expression55,175. In paper III, we documented transcriptional changes in nucleus 
accumbens in formerly germ-free mice colonized with fecal microbiota from an anorectic 
patient. Interestingly, many of the genes affected in our pilot study are known to regulate 
feeding in the hypothalamus. Whether this suggests that the nucleus accumbens is directly 
involved in feeding behavior, or if these genes regulate different functions in the nucleus 
accumbens compared to the hypothalamus, remains to be investigated. Nevertheless, we are 
just beginning to understand the potential relevance of gut microbiota for anorexia nervosa, 
and up to this date, there are only few studies of microbiome profile in anorectic patients with 
small sample sizes. Future studies in larger cohorts aimed to differentiate the causal versus 
effectual role of gut microbiota in anorexia nervosa might lead to a better understanding of 
the etiology of the diseases.  
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